Combined immunodeficiency due to ZAP70 deficiency
zee-ay-pee seventy deficiency
Also known as: ZAP70 SCID, ZAP70-related immunodeficiency
At a Glance
What is Combined immunodeficiency due to ZAP70 deficiency?
Combined immunodeficiency due to ZAP70 deficiency is a rare genetic disorder that affects the immune system, making it difficult for the body to fight off infections. It primarily impacts the lymphatic and immune systems, leading to frequent and severe infections. The condition is caused by mutations in the ZAP70 gene, which is crucial for T-cell receptor signaling. Over time, affected individuals may experience chronic infections, failure to thrive, and developmental delays. Early symptoms often include recurrent respiratory infections and diarrhea, while later symptoms can involve more severe infections and autoimmune complications. Early diagnosis is critical to manage infections and prevent complications. The condition can significantly impact family life, as it requires constant medical attention and care. Prognosis varies, but with early intervention, some individuals can lead relatively normal lives. Daily life for those affected involves regular medical check-ups, infection prevention measures, and sometimes bone marrow transplants. Families may need to adapt their lifestyles to accommodate the medical needs of the affected individual. Support from healthcare professionals and patient communities can be invaluable for managing the condition.
Combined immunodeficiency due to ZAP70 deficiency Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Recurrent infections manifest as frequent and severe bacterial, viral, or fungal infections. This occurs due to the impaired function of T cells, which are crucial for fighting off pathogens. Over time, these infections can become more severe and resistant to standard treatments. Daily life is significantly impacted as patients may require frequent hospitalizations and aggressive antimicrobial therapies.
Failure to thrive is characterized by poor weight gain and growth in infants and children. This results from chronic infections and malabsorption due to gastrointestinal involvement. As the child grows, this can lead to developmental delays and stunted growth. Nutritional support and treatment of underlying infections can help manage this symptom.
Chronic diarrhea presents as persistent loose or watery stools. It is often caused by gastrointestinal infections or malabsorption issues due to immune deficiency. Over time, chronic diarrhea can lead to dehydration and nutritional deficiencies. Management includes rehydration, nutritional support, and treatment of underlying infections.
Common
Lymphopenia is a condition where there is an abnormally low level of lymphocytes in the blood. This occurs due to the defective development and function of T cells. It can lead to increased susceptibility to infections over time. Regular monitoring and immune support therapies can help manage this condition.
Autoimmune manifestations can include conditions such as autoimmune hemolytic anemia or thrombocytopenia. These occur when the immune system mistakenly attacks the body's own cells. Over time, these conditions can cause significant morbidity if not managed properly. Immunosuppressive therapies and regular monitoring are often required.
Skin rashes in ZAP70 deficiency can appear as eczema or other inflammatory skin conditions. They result from immune dysregulation and chronic inflammation. These rashes can become chronic and may flare up periodically. Topical treatments and systemic therapies may be needed to control symptoms.
Less Common
Hepatosplenomegaly is the enlargement of the liver and spleen. It occurs due to chronic immune activation and infiltration by immune cells. Over time, this can lead to abdominal discomfort and potential organ dysfunction. Regular monitoring and addressing the underlying immune dysregulation are essential.
Neurological symptoms can include developmental delays or seizures. These arise from potential central nervous system involvement due to infections or autoimmune processes. Over time, these symptoms can significantly impact quality of life and development. Neurological assessment and tailored therapies are crucial for management.
What Causes Combined immunodeficiency due to ZAP70 deficiency?
ZAP70 deficiency is caused by mutations in the ZAP70 gene, which is located on chromosome 2q12.1. The ZAP70 gene encodes the zeta-chain-associated protein kinase 70, a crucial enzyme in T-cell receptor signaling. Mutations in ZAP70 can lead to the production of a non-functional or absent protein, disrupting T-cell receptor signaling. This disruption impairs T-cell development and function, leading to a compromised adaptive immune response. As a result, the immune system cannot effectively respond to infections, causing immunodeficiency. The lack of functional T-cells affects neighboring immune cells, such as B-cells, leading to broader immune dysfunction. Neuroinflammation may occur due to chronic infections and immune dysregulation, potentially affecting the central nervous system. The degeneration of white matter structures can result from persistent inflammation and immune cell infiltration. Symptoms typically appear as recurrent infections, failure to thrive, and developmental delays due to the immune system's inability to protect against pathogens. The severity of the disease varies depending on the specific mutations and residual protein function, with some patients having partial immune function. In some cases, residual SYK expression in CD8 T cells can provide limited TCR signaling, slightly mitigating the severity. The pattern of symptoms is influenced by the types of infections encountered and the degree of immune compromise. Patients with leaky severe combined immunodeficiency may present with milder symptoms due to partial immune function. The variability in clinical presentation is also influenced by genetic background and environmental factors. Overall, the interplay between genetic mutations, immune system dysfunction, and environmental exposures determines the clinical phenotype.
How is Combined immunodeficiency due to ZAP70 deficiency Diagnosed?
Typical age of diagnosis: Combined immunodeficiency due to ZAP70 deficiency is typically diagnosed in infancy or early childhood when recurrent infections and failure to thrive prompt further investigation.
Clinicians look for signs of recurrent infections, failure to thrive, and developmental delays. A detailed family history is crucial to identify any hereditary patterns of immunodeficiency. Physical examination may reveal lymphadenopathy, hepatosplenomegaly, or skin manifestations. This step helps in suspecting an immunodeficiency disorder and guides further diagnostic testing.
Chest X-rays or CT scans are commonly used imaging modalities. They may reveal abnormalities such as bronchiectasis or lymphoid tissue enlargement. These findings can support the diagnosis of an immunodeficiency by showing structural changes due to chronic infections. Imaging helps exclude other conditions like cystic fibrosis or congenital heart disease.
Specific tests include complete blood count, immunoglobulin levels, and lymphocyte subpopulation analysis. Biomarkers such as low T-cell counts and absent ZAP70 protein expression are sought. Abnormal results typically show reduced CD8+ T cells and impaired T-cell receptor signaling. These results guide the need for genetic testing to confirm the diagnosis.
The ZAP70 gene is sequenced to identify mutations. Mutations can be homozygous or compound heterozygous, often leading to a loss of function. Genetic testing confirms the diagnosis by identifying pathogenic variants in the ZAP70 gene. Results are crucial for family counseling and assessing the risk of recurrence in future offspring.
Combined immunodeficiency due to ZAP70 deficiency Treatment Options
This therapy involves the administration of intravenous or subcutaneous immunoglobulins. It works by providing passive immunity to patients with antibody deficiencies. Specific drugs include IVIG (intravenous immunoglobulin) and SCIG (subcutaneous immunoglobulin). Clinical evidence shows that it reduces infection rates and improves quality of life. Limitations include the need for regular infusions and potential allergic reactions.
Techniques such as chest physiotherapy and breathing exercises are used. The goal is to improve lung function and prevent respiratory complications. Sessions are typically conducted several times a week for optimal results. Measurable outcomes include improved pulmonary function tests and reduced respiratory infections. Long-term benefits include enhanced respiratory health and overall well-being.
This procedure is indicated for severe cases of immunodeficiency. It involves the transplantation of healthy stem cells to reconstitute the immune system. Expected benefits include the potential for a cure and restoration of immune function. Surgical risks include graft-versus-host disease and infection. Post-operative care requires close monitoring and immunosuppressive therapy.
The care team includes immunologists, infectious disease specialists, and nutritionists. Interventions focus on infection prevention, nutritional support, and developmental monitoring. Psychosocial support strategies involve counseling and support groups for families. Family education is provided on infection control and recognizing early signs of illness. Long-term monitoring includes regular follow-ups and immunological assessments.
When to See a Doctor for Combined immunodeficiency due to ZAP70 deficiency
- Severe recurrent infections — indicate a compromised immune system requiring immediate medical evaluation.
- Failure to thrive in infants — may signal underlying immunodeficiency and needs urgent assessment.
- Severe respiratory distress — can indicate serious infection or complication requiring emergency care.
- Chronic diarrhea — can lead to dehydration and malnutrition; consult a doctor for evaluation.
- Persistent skin rashes — may indicate immune dysfunction and should be assessed by a healthcare provider.
- Frequent ear infections — suggest possible immune issues; seek medical advice for further investigation.
- Mild cold symptoms — monitor for worsening signs and maintain hydration.
- Occasional fatigue — track energy levels and ensure adequate rest and nutrition.
Combined immunodeficiency due to ZAP70 deficiency — Frequently Asked Questions
Is this condition hereditary?
Combined immunodeficiency due to ZAP70 deficiency is inherited in an autosomal recessive pattern. This means both copies of the gene in each cell have mutations, and each parent carries one copy of the mutated gene. There is a 25% chance with each pregnancy for carrier parents to have an affected child. De novo mutations are rare in this condition. Genetic counseling is recommended for affected families to understand risks and carrier status.
What is the life expectancy for someone with this condition?
Life expectancy varies significantly depending on the age of onset and access to treatment. Early diagnosis and intervention, such as hematopoietic stem cell transplantation, can significantly improve outcomes. Without treatment, severe infections are a common cause of mortality. With appropriate management, individuals can have a significantly extended lifespan. Realistic expectations should include ongoing medical care and monitoring.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves a combination of clinical evaluation, immunological testing, and genetic analysis. The time from first symptoms to diagnosis can vary, often taking several months due to the rarity of the condition. Immunologists and geneticists are commonly consulted specialists. Delayed diagnosis may occur due to symptom overlap with other immunodeficiencies. Genetic testing confirming ZAP70 mutations establishes the diagnosis.
Are there any new treatments or clinical trials available?
Research is ongoing into gene therapy as a promising treatment for ZAP70 deficiency. Current studies focus on correcting the genetic defect at the cellular level. ClinicalTrials.gov is a resource for finding relevant clinical trials. Patients should discuss potential trial participation with their healthcare provider. New treatments may become available in the next few years, but timelines are uncertain.
How does this condition affect daily life and activities?
Individuals may experience limitations in physical activities due to fatigue and recurrent infections. Educational challenges can arise from frequent absences and cognitive impacts. Social isolation and emotional stress are common due to health-related restrictions. Family members often face increased caregiving responsibilities. Supportive measures include individualized education plans and access to mental health resources.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.[Inherited lymphoproliferative disorders].
Kanegane H, Hoshino A · Rinsho Ketsueki · 2019 · PMID: 31281164
- 2.Defining combined immunodeficiency.
Roifman CM, Somech R, Kavadas F et al. · J Allergy Clin Immunol · 2012 · PMID: 22664165
- 3.A rare disease: ZAP70 deficiency.
Erdogan S, Cakmak SC, Gurkan A et al. · North Clin Istanb · 2024 · PMID: 38757100
- 4.Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder.
Karaca E, Karakoc-Aydiner E, Bayrak OF et al. · Gene · 2013 · PMID: 23124046
- 5.ZAP70 deficiency promotes reverse cholesterol transport through MAPK/ERK pathway in Jurkat cell.
Liu J, Guo K, Hu L et al. · Mol Immunol · 2019 · PMID: 30639475
- 6.SYK expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling.
Hauck F, Blumenthal B, Fuchs S et al. · Clin Immunol · 2015 · PMID: 26187144
- 7.First case of primary CNS lymphoma in a patient with severe combined immunodeficiency carrying a novel ZAP70 mutation: a case report.
Albitar MH, Sayed AG, Joueidi F et al. · Ann Med Surg (Lond) · 2025 · PMID: 40901120
- 8.Novel compound heterozygous mutations in ZAP70 in a Chinese patient with leaky severe combined immunodeficiency disorder.
Liu Q, Wang YP, Liu Q et al. · Immunogenetics · 2017 · PMID: 28124082
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-04